MIMS3: Mental Stress and Myocardial Ischemia After MI: Sex Differences, Mechanisms and Prognosis
Study Details
Study Description
Brief Summary
The purpose of this study is to look at the link between emotional stress and heart disease in men and women. Taking part in this study involves one clinic visit, one week of at home monitoring, and follow up phone calls every 6 months for 3 years.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
In the U.S. and globally, coronary heart disease (CHD) is the number one killer of women. Despite scientific advances, it is unclear whether the pathophysiology of CHD differs between women and men. The study of CHD in women has historically been centered on older women, however, women with early onset CHD are informative for the study of early risk factors and pathophysiology. Furthermore, young women with a myocardial infarction (MI) have emerged as a group in need of special study as this group has higher mortality compared with men of similar age despite less severe disease. These disparities remain unexplained and suggest sex differences in the pathophysiology, risk factors and prognostic factors of acute MI.
The psychosocial sphere is a largely neglected area for CHD prevention in women. Social and emotional exposures mostly beginning early in life (depression, early life adversities, poverty and posttraumatic stress symptoms) are more common in younger women with MI compared with men and community controls. In addition to being more prevalent, it is possible that emotional stress is a stronger risk factor in young women than other groups. A significant challenge, however, is to measure stress in a valid way.
Building on previous work, the current project will clarify sex differences in pathways of risk linking emotional stress to mental stress-induced myocardial ischemia (MSI) and cardiovascular outcomes in young post-MI patients. Within 8 months of MI, 300 patients ≤60 years of age (at the time of the MI), 50% women, will be tested in the lab with a stress challenge to asses MSI using an established protocol with myocardial perfusion imaging. Participants will be monitored at home for 1 week, and then followed for clinical events for 3 years.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Other: Young Participants with Prior MI Participants aged 60 or less who experienced a MI within the last 8 months will undergo a stress challenge to assess MSI and will then be followed for 3 years. |
Other: Stress Challenge
The stress challenge will assess how different parts of the body react to stress. Participants will be given no specific details about the contents of the test before administration.
|
Outcome Measures
Primary Outcome Measures
- Cardiovascular Events [3 Years]
The main outcome will be a composite endpoint of recurrent MI, unstable angina, hospitalization for decompensated heart failure, and cardiovascular (CV) death. A mental stress-induced myocardial ischemia (MSI) status of positive or negative will be the main predictor in regression models.
Secondary Outcome Measures
- Myocardial Infarction or Cardiovascular Death [3 Years]
The number of participants experiencing myocardial infarction or CV death in relation to MSI status (positive or negative).
- Cardiovascular Death [3 Years]
The number of participants experiencing CV death in relation to MSI status (positive or negative).
- Total Mortality [3 Years]
The number of participants experiencing all-cause death in relation to MSI status (positive or negative).
- Cardiovascular Events Excluding Heart Failure [3 Years]
This is a composite endpoint of recurrent MI, unstable angina, or CV death where the number of participants experiencing this endpoint in relation to MSI status (positive or negative) will be examined.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
History of documented MI within the past 8 months
-
Age ≤60 at the time of MI
Exclusion Criteria:
-
History of unstable angina, MI, or decompensated heart failure in past month
-
Patients deemed to be unsafe to hold anti-ischemic medications before testing (it is standard protocol to hold these meds before imaging studies)
-
Systolic blood pressure (SBP) >170 mm Hg or diastolic blood pressure (DBP) >100 mm Hg on the day of the test
-
Alcohol or substance abuse (past year), or severe psychiatric disorder other than major depression
-
Other serious medical disorder that may interfere with the study results
-
Postmenopausal hormone therapy (past 3 months)
-
Current psychotropic medications (past month) except anti-depressants
-
Pregnancy or breast feeding (all women will receive a pregnancy test)
-
Severe aortic stenosis
-
Weight ≥ 350 pounds and/or body mass index (BMI) of 40 or greater (weIght limit of the SPECT imaging table)
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Emory University Hospital | Atlanta | Georgia | United States | 30322 |
| 2 | Grady Health System | Atlanta | Georgia | United States | 30322 |
| 3 | The Emory Clinic | Atlanta | Georgia | United States | 30322 |
Sponsors and Collaborators
- Emory University
- National Heart, Lung, and Blood Institute (NHLBI)
Investigators
- Principal Investigator: Viola Vaccarino, MD, PhD, Emory University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IRB00113346
- 2R01HL109413-05A1